Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F14%3A10218654" target="_blank" >RIV/00216208:11140/14:10218654 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61388971:_____/14:00435673 RIV/00669806:_____/14:10218654
Výsledek na webu
<a href="http://dx.doi.org/10.1016/j.biologicals.2014.01.003" target="_blank" >http://dx.doi.org/10.1016/j.biologicals.2014.01.003</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.biologicals.2014.01.003" target="_blank" >10.1016/j.biologicals.2014.01.003</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment
Popis výsledku v původním jazyce
Mesenchymal stromal cells (MSC) are fibroblast-like cells present in different types of tissues. Their immunomodulatory potential represents a promising method for post-transplant immunotherapy in the treatment of GVHD (graft-versus-host disease) with suboptimal response to standard immunosuppression. In this study we tested influence of 1e8 month-long cryopreservation on ability of MSC to suppress activation of non-specifically stimulated lymphocytes. We did not observe any changes in proliferation capacity of MSC after thawing. Lymphocytes metabolic activity was inhibited by 30% and number of dividing cells was three times smaller in the presence of MSC. Two activation markers were studied (CD25 and CD69) to confirm preservation of functional cell integrity. Expression of CD25 antigen on CD3ţCD4ţ and CD3ţCD4 cells was decreased in all cocultivated samples. Level of CD69 expression on CD3ţCD4ţ cells was lower in samples with added MSC (10e15% on day ţ2) but without reaching statistica
Název v anglickém jazyce
Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment
Popis výsledku anglicky
Mesenchymal stromal cells (MSC) are fibroblast-like cells present in different types of tissues. Their immunomodulatory potential represents a promising method for post-transplant immunotherapy in the treatment of GVHD (graft-versus-host disease) with suboptimal response to standard immunosuppression. In this study we tested influence of 1e8 month-long cryopreservation on ability of MSC to suppress activation of non-specifically stimulated lymphocytes. We did not observe any changes in proliferation capacity of MSC after thawing. Lymphocytes metabolic activity was inhibited by 30% and number of dividing cells was three times smaller in the presence of MSC. Two activation markers were studied (CD25 and CD69) to confirm preservation of functional cell integrity. Expression of CD25 antigen on CD3ţCD4ţ and CD3ţCD4 cells was decreased in all cocultivated samples. Level of CD69 expression on CD3ţCD4ţ cells was lower in samples with added MSC (10e15% on day ţ2) but without reaching statistica
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/ED2.1.00%2F03.0076" target="_blank" >ED2.1.00/03.0076: Biomedicínské centrum Lékařské fakulty v Plzni</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Biologicals
ISSN
1045-1056
e-ISSN
—
Svazek periodika
42
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
6
Strana od-do
139-144
Kód UT WoS článku
000337775200002
EID výsledku v databázi Scopus
—